Fig. 4From: Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI studyRepresentative images of a patient with pseudoprogression. Axial FLAIR (a) and contrast-enhanced T1WI (b) showed a necrotic contrast-enhancing lesion in the right temporal lobe. The lesion disappeared after 6 cycles of temozolomide chemoradiation, which was defined as pseudoprogression. The ADC (c), D (d), D* (e), f (f), DDC (g) and α (h) maps were calculated automatically from the MADC softwareBack to article page